Skip to content

Clinical trials

Breast Neoplasms trials in Indonesia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Country / region: Indonesia Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20092
20112
20122
20131
20172
20181
20191
20201
20213
20223
20232
20243
20251
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting4
Unknown status4
Not yet recruiting2
Approved for marketing1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dharmais National Cancer Center Hospital4
Nalagenetics Pte Ltd4
Gadjah Mada University3
Dexa Medica Group2
Hoffmann-La Roche2
Aldy Aldy1
AstraZeneca1
Chairul Huda1
DINA KEUMALA SARI1
Dong-A ST Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms32
Neoplasm Metastasis4
Neoplasms3
Postoperative Pain3
Lymphedema2
Acute Pain1
Anemia1
Fatigue1
Genetic Risk Score1
Inflammation1

Trials

Showing 26 to 32 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.